Quantitative Evaluation of Model‐Informed Drug Development Implementation in China's Approved Innovative Drugs: From Policy to Practice (2018–2024)
ABSTRACT Model‐informed drug development (MIDD) has emerged as a cornerstone paradigm in global pharmaceutical innovation. Historically underutilized in China, MIDD methodologies gained momentum following the National Medical Products Administration's (NMPA) 2020 release of the Model‐Informed Drug D...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2026-02-01
|
| Seri Bilgileri: | CPT: Pharmacometrics & Systems Pharmacology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/psp4.70211 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|